Inventor · disambiguated record
Brian K. Albrecht
Also filed as: ALBRECHT BRIAN K
52 granted patents·10 pending applications·496 citations·filing 2005–2018
98Inventor score
Files withCONSTELLATION PHARMACEUTICALS INC21GENENTECH INC16ALBRECHT BRIAN K12AMGEN INC8ARORA SHILPI1
Top patents by PatentIndex Score
62 records- 0197US9469646B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Oct 18, 2016·21 cites·4 claims
- 0297US9249161B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Feb 2, 2016·50 cites·12 claims
- 0396US9409865B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Aug 9, 2016·14 cites·3 claims
- 0494US8198448B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2008·Granted Jun 12, 2012·50 cites·38 claims
- 0594US7776869B2Heteroaryl-substituted alkyne compounds and method of useAMGEN INC·Filed 2005·Granted Aug 17, 2010·20 cites·15 claims
- 0693US9085583B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION—PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·18 cites·14 claims
- 0793US9066954B2Fused heterocyclic derivatives and methods of useAMGEN INC·Filed 2013·Granted Jun 30, 2015·22 cites·9 claims
- 0893US8212041B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2007·Granted Jul 3, 2012·47 cites·32 claims
- 0992US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 1092US9051269B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Jun 9, 2015·9 cites·7 claims
- 1192US8796261B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2011·Granted Aug 5, 2014·21 cites·28 claims
- 1292US8524900B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Granted Sep 3, 2013·23 cites·8 claims
- 1392US8217177B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2008·Granted Jul 10, 2012·26 cites·51 claims
- 1491US9371331B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·8 cites·9 claims
- 1591US9206128B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·10 cites·17 claims
- 1691US7880000B2Protein kinase modulators and method of useAMGEN INC·Filed 2005·Granted Feb 1, 2011·21 cites·19 claims
- 1790US9624244B2Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Apr 18, 2017·8 cites·6 claims
- 1890US9328117B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2012·Granted May 3, 2016·8 cites·15 claims
- 1987US10308614B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jun 4, 2019·4 cites·21 claims
- 2087US9745305B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·11 cites·17 claims
- 2187US9522920B2Bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Dec 20, 2016·10 cites·21 claims
- 2286US10016405B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jul 10, 2018·3 cites·4 claims
- 2386US9422292B2Bromodomain inhibitors and uses thereofALBRECHT BRIAN K·Filed 2012·Granted Aug 23, 2016·5 cites·17 claims
- 2486US8476434B2Protein kinase modulators and method of useGEUNS-MEYER STEPHANIE D·Filed 2010·Granted Jul 2, 2013·17 cites·9 claims
- 2586US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 2685US9980952B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·8 claims
- 2785US9969716B2Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted May 15, 2018·4 cites·21 claims
- 2884US11529347B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Dec 20, 2022·4 cites·8 claims
- 2983US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 3083US8557996B2Heteroaryl-substituted alkyne compounds and method of useCHAFFEE STUART C·Filed 2010·Granted Oct 15, 2013·11 cites·13 claims
- 3180US10526287B2LSD1 inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jan 7, 2020·2 cites·22 claims
- 3279US10183009B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jan 22, 2019·3 cites·22 claims
- 3379US9505767B2Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitorsGENENTECH INC·Filed 2014·Granted Nov 29, 2016·4 cites·3 claims
- 3478US10239861B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Mar 26, 2019·2 cites·7 claims
- 3578US8691838B2Heterocycles as protein kinase inhibitorsALBRECHT BRIAN K·Filed 2009·Granted Apr 8, 2014·3 cites·5 claims
- 3677US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 3773US9925197B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·1 cites·5 claims
- 3872US9493483B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·1 cites·8 claims
- 3972US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 4070US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 4169USRE47428EModulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·4 claims
- 4268US10150767B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Dec 11, 2018·1 cites·14 claims
- 4368US10035801B2Pyrazolo compounds and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Jul 31, 2018·1 cites·15 claims
- 4466US2019125737A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4564US2015376190A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4655US2017333406A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4750US2016143910A1Methods of treating cancer and preventing cancer drug resistanceARORA SHILPI·Filed 2014·Application pending·0 cites
- 4849US8314087B2Nitrogen-containing heterocyclyl ketones and methods of useALBRECHT BRIAN K·Filed 2008·Granted Nov 20, 2012·0 cites·6 claims
- 4947US10358437B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Jul 23, 2019·0 cites·9 claims
- 5047US2012107275A1Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Brian K. Albrecht files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →